Blood pressure reducing medications containing valsartam, an active ingredient produced by China's Zhejiang Huahai Pharmaceuticals, are being recalled in Lithuania as they may contain impurities capable of causing cancer.
© DELFI / Karolina Pansevič

Žydrūnas Martinėnas, deputy director of Lithuania's State Medicines Control Agency, told BNS Lithuania that the potential risk of the identified impurities is being assessed by the European Medicines Agency.

In his words, there are market alternatives with the same active ingredient to the recalled medications.

"New medications should be prescribed by the doctor," Martinėnas told BNS Lithuania.

The medications might have been contaminated with impurities during the manufacturing process, the Lithuania's State Medicines Control Agency said.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.
Leave a comment
or for anonymous commenting click here
By posting, you agree to terms
Read comments Read comments

Gender equality is human right, and it is great for society. Let’s listen to Norwegians

Even though Lithuania has achieved a lot in gender equality, it is still a long way to go, especially...

Kaunas is the most innovative city in Lithuania - expert

Less talked about Kaunas startup world is experiencing a breakthrough. Products developed in city’s...

World War One memorial service held at Vilnius International Church

On Sunday November 11th a World War One memorial remembrance service was held at the Vilnius...

Pope Francis confirms Lithuanian Giedraitis as blessed

Mykolas Giedraitis, a secular Augustinian born in Lithuania in the 15th century, has been confirmed as...

Lithuania's emigration rate falls, but more people leave than arrive

Lithuania's emigration rate fell by 14.2 percent in the ten months of 2018 compared with a year ago,...